{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:22:15Z","timestamp":1783488135902,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T00:00:00Z","timestamp":1520467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004321","name":"Shire","doi-asserted-by":"publisher","award":["IIR-ITA-001135"],"award-info":[{"award-number":["IIR-ITA-001135"]}],"id":[{"id":"10.13039\/501100004321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00223-018-0405-5","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T02:23:21Z","timestamp":1520475801000},"page":"144-150","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Prevalence of Chronic Hypoparathyroidism in a Mediterranean Region as Estimated by the Analysis of Anonymous Healthcare Database"],"prefix":"10.1007","volume":"103","author":[{"given":"Luisella","family":"Cianferotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Parri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Gronchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Marcucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Raglianti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Minisola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8741-0592","authenticated-orcid":false,"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,8]]},"reference":[{"key":"405_CR1","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1210\/jc.2015-3909","volume":"101","author":"DM Shoback","year":"2016","unstructured":"Shoback DM, Bilezikian JP, Costa AG, Dempster D, Dralle H, Khan AA, Peacock M, Raffaelli M, Silva BC, Thakker RV, Vokes T, Bouillon R (2016) Presentation of hypoparathyroidism: etiologies and clinical features. J Clin Endocrinol Metab 101:2300\u20132312","journal-title":"J Clin Endocrinol Metab"},{"key":"405_CR2","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1210\/jc.2015-3908","volume":"101","author":"BL Clarke","year":"2016","unstructured":"Clarke BL, Brown EM, Collins MT, J\u00fcppner H, Lakatos P, Levine MA, Mannstadt MM, Bilezikian JP, Romanischen AF, Thakker RV (2016) Epidemiology and diagnosis of hypoparathyroidism. J Clin Endocrinol Metab 101:2284\u20132299","journal-title":"J Clin Endocrinol Metab"},{"key":"405_CR3","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-15-0628","volume":"173","author":"J Bollerslev","year":"2015","unstructured":"Bollerslev J, Rejnmark L, Marcocci C, Shoback DM, Sitges-Serra A, van Biesen W, Dekkers OM, European Society of Endocrinology (2015) European Society of Endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol 173:G1\u2013G20","journal-title":"Eur J Endocrinol"},{"key":"405_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","volume":"1","author":"M Mannstadt","year":"2013","unstructured":"Mannstadt M, Clarke BL, Vokes T, Brandi ML, Ranganath L, Fraser WD, Lakatos P, Bajnok L, Garceau R, Mosekilde L, Lagast H, Shoback D, Bilezikian JP (2013) Efficacy and safety of recombinant human parathyroid hormone (1\u201384) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Lancet Diabetes Endocrinol 1:275\u2013283","journal-title":"Lancet Diabetes Endocrinol"},{"key":"405_CR5","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1210\/jc.2015-3910","volume":"101","author":"JP Bilezikian","year":"2016","unstructured":"Bilezikian JP, Brandi ML, Cusano NE, Mannstadt M, Rejnmark L, Rizzoli R, Rubin MR, Winer KK, Liberman UA, Potts JT Jr (2016) Management of hypoparathyroidism: present and future. J Clin Endocrinol Metab 101:2313\u20132324","journal-title":"J Clin Endocrinol Metab"},{"key":"405_CR6","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1080\/14740338.2017.1311322","volume":"16","author":"G Marcucci","year":"2017","unstructured":"Marcucci G, Della Pepa G, Brandi ML (2017) Drug safety evaluation of parathyroid hormone for hypocalcemia in patients with hypoparathyroidism. Expert Opin Drug Saf 16:617\u2013625","journal-title":"Expert Opin Drug Saf"},{"key":"405_CR7","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/jbmr.2004","volume":"28","author":"J Powers","year":"2013","unstructured":"Powers J, Joy K, Ruscio A, Lagast H (2013) Prevalence and incidence of hypoparathyroidism in the United States using a large claims database. J Bone Miner Res 28:2570\u20132576","journal-title":"J Bone Miner Res"},{"key":"405_CR8","doi-asserted-by":"publisher","first-page":"S182","DOI":"10.1002\/jbmr.210","volume":"26","author":"BL Clarke","year":"2011","unstructured":"Clarke BL, Leibson C, Emerson J, Ransom JE, Lagast H (2011) Co-morbid medical conditions associated with prevalent hypoparathyroidism: a popualtion-based study. J Bone Miner Res 26:S182 (Abstract SA1070)","journal-title":"J Bone Miner Res"},{"key":"405_CR9","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1002\/jbmr.1979","volume":"28","author":"L Underbjerg","year":"2013","unstructured":"Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2013) Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res 28:2277\u20132285","journal-title":"J Bone Miner Res"},{"key":"405_CR10","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/jbmr.2501","volume":"30","author":"L Underbjerg","year":"2015","unstructured":"Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2015) The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study. J Bone Miner Res 30:1738\u20131744","journal-title":"J Bone Miner Res"},{"key":"405_CR11","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1210\/jc.2016-1477","volume":"101","author":"MC Astor","year":"2016","unstructured":"Astor MC, L\u00f8v\u00e5s K, Debowska A, Eriksen EF, Evang JA, Fossum C, Fougner KJ, Holte SE, Lima K, Moe RB, Myhre AG, Kemp EH, Nedreb\u00f8 BG, Svartberg J, Husebye ES (2016) Epidemiology and health-related quality of life in hypoparathyroidism in Norway. J Clin Endocrinol Metab 101:3045\u20133053","journal-title":"J Clin Endocrinol Metab"},{"key":"405_CR12","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s00223-016-0222-7","volume":"100","author":"C Cipriani","year":"2017","unstructured":"Cipriani C, Pepe J, Biamonte F, Manai R, Biondi P, Nieddu L, Cianferotti L, Brandi ML, Minisola S (2017) The epidemiology of hypoparathyroidism in Italy: an 8-year register-based study. Calcif Tissue Int 100:278\u2013285","journal-title":"Calcif Tissue Int"},{"key":"405_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12020-015-0606-x","volume":"50","author":"L Cianferotti","year":"2015","unstructured":"Cianferotti L, Cricelli C, Kanis JA, Nuti R, Reginster JY, Ringe JD, Rizzoli R, Brandi ML (2015) The clinical use of vitamin D metabolites and their potential developments: a position statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO) and the international osteoporosis foundation (IOF). Endocrine 50:12\u201326","journal-title":"Endocrine"},{"key":"405_CR14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-88-470-5376-2_25","volume-title":"Hypoparathyroidism","author":"L Masi","year":"2015","unstructured":"Masi L (2015) Refractory hypoparathyroidism. In: Brandi ML, Brown EM (eds) Hypoparathyroidism. Springer, London, pp\u00a0279\u2013286"},{"key":"405_CR15","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1007\/s00198-015-3187-x","volume":"26","author":"L Cianferotti","year":"2015","unstructured":"Cianferotti L, Parri S, Gronchi G, Rizzuti C, Fossi C, Black DM, Brandi ML (2015) Changing patterns of prescription in vitamin D supplementation in adults: analysis of a regional dataset. Osteoporos Int 26:2695\u20132702","journal-title":"Osteoporos Int"},{"key":"405_CR16","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.semnephrol.2014.10.002","volume":"34","author":"DJ Goldsmith","year":"2014","unstructured":"Goldsmith DJ, Massy ZA, Brandenburg V (2014) The uses and abuses of Vitamin D compounds in chronic kidney disease-mineral bone disease (CKD-MBD). Semin Nephrol 34:660\u2013668","journal-title":"Semin Nephrol"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-018-0405-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-018-0405-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-018-0405-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T03:12:54Z","timestamp":1603941174000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-018-0405-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,8]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["405"],"URL":"https:\/\/doi.org\/10.1007\/s00223-018-0405-5","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,8]]},"assertion":[{"value":"29 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"S.M. has served as speaker for Abiogen, Amgen, Bruno Farmaceutici, Diasorin, Eli Lilly, Italfarmaco, Fujii, Merck Sharp & Dohme, Takeda. He has also served in the advisory board of Amgen, Eli Lilly and Merck Sharp & Dohme and received consultancy fees from Bruno Farmaceutici. M.L.B. has received consultancy fees and grant support from Alexion, Abiogen, Amgen, Eli Lilly, and Shire. L.C., S.P., G.G., G.M., C.C., J.P., and M.R., have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}